The Intra-Individual Variability of Faecal Calprotectin: A Prospective Study In Patients With Active Ulcerative Colitis

被引:176
作者
Lasson, Anders [1 ]
Stotzer, Per-Ove [2 ]
Ohman, Lena [2 ,3 ]
Isaksson, Stefan [2 ,3 ]
Sapnara, Maria [3 ]
Strid, Hans [2 ]
机构
[1] Sodra Alvsborgs Hosp, Dept Internal Med, S-40182 Boras, Sweden
[2] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Dept Biomed, Gothenburg, Sweden
关键词
Ulcerative colitis; Calprotectin; Disease activity; INFLAMMATORY-BOWEL-DISEASE; GRANULOCYTE MARKER PROTEIN; EVIDENCE-BASED CONSENSUS; CROHNS-DISEASE; INTESTINAL INFLAMMATION; 5-AMINOSALICYLIC ACID; SURROGATE MARKERS; BLOOD LEUKOCYTES; ACTIVITY INDEX; DEFINITIONS;
D O I
10.1016/j.crohns.2014.06.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Leukocyte-derived proteins in faeces, especially calprotectin, are increasingly used to assess disease activity in ulcerative colitis. The objectives of the present study were to assess the importance of factors related to the stool sampling procedure. Methods: For 2 days, patients with active ulcerative colitis collected two stool samples at each bowel movement. The time of defecation, consistency and presence of blood were self-recorded in a diary. The variability in the concentrations of calprotectin during the day and between two consecutive days was assessed, as was the stability of calprotectin concentrations in samples stored at room temperature. Results: Altogether, 18 patients collected 287 stool samples. The intraclass correlation coefficient in pairs of samples from 132 bowel movements was 0.79 (95% CI 0.48-0.90). The median individual coefficient of variation in samples collected during the same day was 52% (4-178). There was a correlation between the level of calprotectin and the time between bowel movements (r = 0.5; p = 0.013). After 3 days at room temperature the calprotectin concentrations in stool samples were unchanged, but after 7 days a significant (p < 0.01) decrease was found (mean 28%; 95% CI 0.10-0.47). Conclusion: The present data reveal a great variability in the concentrations of calprotectin in stool samples collected during a single day. Since the levels of calprotectin increased with longer time between the bowel movements, it seems most appropriate to analyse stool from the first bowel movement in the morning. Moreover, storage of stool samples at room temperature for more than 3 days is not advisable.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 25 条
[1]   Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease [J].
Costa, F ;
Mumolo, MG ;
Ceccarelli, L ;
Bellini, M ;
Romano, MR ;
Sterpi, C ;
Ricchiuti, A ;
Marchi, S ;
Bottai, M .
GUT, 2005, 54 (03) :364-368
[2]   Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease [J].
D'Haens, Geert ;
Ferrante, Marc ;
Vermeire, Severine ;
Baert, Filip ;
Noman, Maja ;
Moortgat, Liesbeth ;
Geens, Patricia ;
Iwens, Doreen ;
Aerden, Isolde ;
Van Assche, Gert ;
Van Olmen, Gust ;
Rutgeerts, Paul .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) :2218-2224
[3]   Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis [J].
Dignass, Axel ;
Eliakim, Rami ;
Magro, Fernando ;
Maaser, Christian ;
Chowers, Yehuda ;
Geboes, Karel ;
Mantzaris, Gerassimos ;
Reinisch, Walter ;
Colombel, Jean-Frederic ;
Vermeire, Severine ;
Travis, Simon ;
Lindsay, James O. ;
Van Assche, Gert .
JOURNAL OF CROHNS & COLITIS, 2012, 6 (10) :965-990
[4]   Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology [J].
Dolwani, S ;
Metzner, M ;
Wassell, JJ ;
Yong, A ;
Hawthorne, AB .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (06) :615-621
[5]   Faecal calprotectin in the assessment of Crohn's disease activity [J].
Gaya, DR ;
Lyon, TDB ;
Duncan, A ;
Neilly, JB ;
Han, S ;
Howell, J ;
Liddell, C ;
Stanley, AJ ;
Morris, AJ ;
Mackenzie, JF .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2005, 98 (06) :435-441
[6]   Fecal Calprotectin Levels Predict the Clinical Course in Patients With New Onset of Ulcerative Colitis [J].
Lasson, Anders ;
Simren, Magnus ;
Stotzer, Per-Ove ;
Isaksson, Stefan ;
Ohman, Lena ;
Strid, Hans .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (03) :576-581
[7]   Stool form scale as a useful guide to intestinal transit time [J].
Lewis, SJ ;
Heaton, KW .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (09) :920-924
[8]   Fecal Calprotectin Variability in Crohn's Disease [J].
Moum, Bjorn ;
Jahnsen, Jorgen ;
Bernklev, Tomm .
INFLAMMATORY BOWEL DISEASES, 2010, 16 (07) :1091-1092
[9]   A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease [J].
Naismith, G. D. ;
Smith, L. A. ;
Barry, S. J. E. ;
Munro, J. I. ;
Laird, S. ;
Rankin, K. ;
Morris, A. J. ;
Winter, J. W. ;
Gaya, D. R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (06) :613-621
[10]   COATED MESALAZINE (5-AMINOSALICYLIC ACID) VERSUS SULPHASALAZINE IN THE TREATMENT OF ACTIVE ULCERATIVE-COLITIS - A RANDOMIZED TRIAL [J].
RACHMILEWITZ, D .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 298 (6666) :82-86